Taking in Biological Technology

Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections

AUSTIN, Texas, July 27 /PRNewswire/ -- Patton Medical Devices, manufacturer of the i-port(R) and a leader of injection port therapy, announced today that they have entered into a partnership agreement with Unomedical, a leading manufacturer of single use medical devices used in th...

Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008

SAN FRANCISCO, Nov. 24 /PRNewswire/ -- Diagnostic Imaging will produce its 11th Annual Webcast From the RSNA based on proceedings from the upcoming Radiology Society of North America Scientific Assembly and Annual Meeting taking place in Chicago, IL, from November 30th through December 5th. This ...

Miniaturizing memory: Taking data storage to the molecular level

Computers are getting smaller and smaller. And as hand-held devices from mobile phones and cameras to music players and laptops get more powerful, the race is on to develop memory formats that can satisfy the ever-growing demand for information storage on tiny formats. Researchers at The Univ...

Tiny refrigerator taking shape to cool future computers

WEST LAFAYETTE, Ind. - Researchers at Purdue University are developing a miniature refrigeration system small enough to fit inside laptops and personal computers, a cooling technology that would boost performance while shrinking the size of computers. Unlike conventional cooling systems, which ...

Kiwa Bio-Tech Passes Test & Taking Orders From Beijing Lv Fu Long Vegetable Company

BEIJING and CLAREMONT, Calif., May 14 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced that based on results of testing of Kiwa's bio-fertilizer product, Beijing Lv Fu Long Vegetable Company will start placing orders for Kiwa Shando...

CaviWipes(R): Taking Surface Disinfection to a New Level

Unique design offers enhanced convenience, ease-of-use, and helps optimize space ORANGE, Calif., March 3 /PRNewswire/ -- Metrex Research Corporation is pleased to announce the newest member of its surface disinfection line, CaviWipes in a flat pack. Its unique pa...

Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes

Emmy Nominated Actress Shares Her Personal Story and Tips for Better Blood Sugar Management BRIDGEWATER, N.J., Nov. 1 /PRNewswire-FirstCall/ -- As one of the more than 20 million Americans living with diabetes, Emmy nominated actress and Broadway star Aida Turturro is...

Sound Focus plans to enter home-entertainment market after taking Governor's prize

Sound Focus has a plan: rework home entertainment with a speaker system that can project different sounds to different places without complicated acoustic engineering. That plan won top honors in the information technology category at Wisconsin Gov. Jim Doyle's first annual business-plan contest...

Six signs you may be taking yourself too seriously at work

CHICAGO I recently saw a funny thing: a police officer at Midway Airport riding a Segway . As he glided along, the officer kept the most gruff and serious expression on his face (all the better to counteract how goofy he looked on that thing). Nothing against the officer but anyone looks id...

Info Security: Taking a page from the 1950s

What would the world be like without a cold war and arms race? For IT at least, were still waiting to find out. Info security is the new battleground with a steady escalation of words and armor. The latest secret weapon? Those cuddly, camp little iPods everyone is carrying around in their pockets...

Companies are still taking software license

Madison , Wis. - Software piracy remains pervasive in American and foreign businesses, but those who track it are getting better at cracking down, and violators have been paying a stiff price. Research indicates that one in five software programs in use in the United States is unlicensed,...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...arget for launches thereafter. Down Syndrome Test - The company is evaluating both RNA and DNA approaches for a Down syndrome test, and it is taking a rigorous and detailed approach to this work. The company is also sponsoring a number of clinical studies through independent third parties, the resu...

The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict

..., California awarded over $6 million to an 82 year-old Chinese female immigrant who suffered Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis after taking the drug Allopurinol. She alleged that the Defendant, an osteopathic physician and registered pharmacist, prescribed it to her for gout. Plaintiff d...

PDI Reports 2009 Second Quarter Financial Results

...more solid competitive stance, including leveraging and expanding our core CSO capabilities, strategically adding to management, reducing expenses and taking appropriate charges in order to better structure the Company for future success. We are confident that adherence to this strategy will put us on a tra...

TSH Testing Raises Awareness of Importance of Thyroid Health

...l Cancer Institute is looking at Iodine 131, the most probable cause of thyroid damage produced by a nuclear malfunction," said Mangano. "The study is taking place right now in Belarus. We have known for a long time that gamma rays and X-rays affect the thyroid but no one has really studied the effects of I...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...e inflammatory disease for over 50 years. Patients taking Benlysta plus a standard treatment for one year ha...in, rashes and infections - compared with patients taking standard treatment plus placebo. The study involve...atients in Asia, South America and Eastern Europe. taking advantage of its strong share value, the company i...

America's Organic Home-Fueling Movement Begins in Los Angeles

...hris Ursitti, CEO of GreenHouse, the company is gearing up for commercial distribution in Southern California by the fourth quarter of 2009 and is now taking preorders for the unit. To see the first home installation of the MicroFueler, click on the video on the left-hand side of this release. For ...

Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software

... Kim Terry, President of Terrosa Technologies. inclinicalperform's collaboration software platform will benefit the clinical research community by taking much of the manual work out of tracking, monitoring and aggregating information that is created during the clinical trials process. "Our software...

Cornerstone Therapeutics Announces Closing of Chiesi Transaction

...tions on favorable terms, if at all; our ability to maintain compliance with NASDAQ listing requirements; adverse side effects experienced by patients taking our products; difficulties relating to clinical trials, including difficulties or delays in the completion of patient enrollment, data collection or d...

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

...f operation, small size (it fits in the palm of the hand), light weight, and battery use, products incorporating eFlow Technology reduce the burden of taking daily, inhaled treatments. The investigational eFlow Nebulizer System and eFlow Technology are proprietary to PARI Pharma and can be optimized to spe...

Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)

...o features: W. Hayes Wilson, M.D. , Chief, Division of Rheumatology at Piedmont Hospital in Atlanta, Georgia, who discusses the importance of taking charge of your health and two-way communication with a doctor. Laurie Ferguson, Ph.D. , Vice President of Research and Education at the advoca...

Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors

...d safety of ganaxolone in the treatment of both children and adults suffering from refractory epilepsy (patients who continue to have seizures despite taking multiple anticonvulsant drugs). Marinus has successfully developed several proprietary and novel patented formulations of ganaxolone. A...

Sanofi-aventis Announces Second Quarter 2009 Results

...ble effects of some other currencies. At constant exchange rates, and after taking account of changes in structure (in particular the consolidation of Zentiva...had a favorable effect of 3.6 points. At constant exchange rates, and after taking account of changes in structure (in particular the consolidation of Zentiva...

GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles

..., CEO of GreenHouse, stated that the company is gearing up for commercial distribution in Southern California by the fourth quarter of 2009 and is now taking preorders for the unit. "With the launch of the first operational MicroFueler in Los Angeles, GreenHouse is making consumer-use of E-Fuel100 an ...

Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting

...ig Ziering, founder of Ziering Medical and principal investigator on the clinical trial, addressed attendees on July 25th, 2009 during the conference, taking place in Amsterdam July 22-26, 2009. HSC is a proprietary formulation of naturally secreted embryonic proteins, growth factors and contains ...

Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting

...." Varian will also exhibit other products and capabilities at the 2009 meeting of the American Association of Physicists in Medicine (AAPM), taking place here from July 26-30, including: A new "knowledge based" automatic segmentation tool (acquired last month from Houston-based IKO...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

...rcent) in the dose-optimization phase for patients taking Vyvanse were decreased appetite, insomnia, headach... last 14 days. Tell the doctor before taking Vyvanse if you or your child is being treated for ...develops any of these conditions or symptoms while taking Vyvanse. Abuse of amphetamines may lead ...

Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International

...thodology, which CDI has dubbed iPS 2.0((TM)), alleviates safety concerns over the use of iPS cells in therapeutic settings and removes the barrier of taking the technology into a clinical setting. (See illustration, iPS 2.0: A Step Closer to Personalized Medicine .) Yu published her initial gro...

A drug-dispensing contact lens

... taking eye drops multiple times a day can be difficult for patients to do, and because of blinking and tearing, as little as 1 to 7 percent of the dose is ac...

SynCo Bio Partners Increases its Capacities by Expanding its Quality Team

...rategic, long-term partner delivering product on time to the highest quality standards. SynCo 's team are committed to exceeding customer expectations taking a truly collaborative approach to manufacturing. http://www.syncobiopartners.com ...

LS9's UltraClean Diesel Exceeds United States & Brazilian Fuels Specifications

...n to bring environmentally friendly fuels to the world market," said Bill Haywood, Chief Executive Officer of LS9. "A fundamental change is taking place in the biofuels landscape, and our ability to produce low-carbon fuels that are ready for today's market puts LS9 at the forefront of this movem...

Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo

...tion-based and send-out practices have missed those children most at-risk for lead poisoning, policy-makers at the federal, state, and local level are taking action to encourage the use of LeadCare II to ensure that children receive mandated testing. In 2009, the National Committee for Quality Assurance (NC...

avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign

...tives to drive sales in targeted market areas." Avvaa recognizes that having an online presence is paramount these days, and as such, the Company is taking the steps to build a dynamic website that is easy to navigate, informative and communicates the Company's message the best way possible. The core pr...

Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System

...romes, peripheral vascular disease or in patients with uncontrolled hypertension. Very rarely, serious cardiac adverse events have been reported when taking sumatriptan, including patients with no findings of cardiovascular disease. Considering the extent of use of sumatriptan in patients with migraine, th...

UCSF researchers help crack parasite genome, identify drug leads

...lth." Caffrey said the disease places an estimated 600-700 million people at risk of infection. The parasite actively infects humans via the skin, taking approximately 6 weeks to reach adulthood and reproduce. For disease transmission, those eggs must be evacuated in urine or feces into fresh water, whe...

EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimer's Disease

...tially useful clinical effect." In this Phase Ib/IIa safety and biomarker study in patients with mild to moderate Alzheimer's disease already taking chronic acetylcholinesterase inhibitor (AChEI) therapy (donepezil or rivastigmine), three separate doses of EVP-6124 or a placebo dose were administer...

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

...nnual Meeting. The meeting is being held in Vancouver, British Columbia, from July 11-15, 2009. "These results support the strategic direction we're taking with the REOLYSIN(R) clinical program," said Dr. Matt Coffey, Chief Operating Officer for Oncolytics. "The future program for REOLYSIN, including our ...

ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference

... of life sciences executives on the topic of "Capitalizing on Trends in Negotiation, Contracts, and Risk and Reward." The panel discussion, taking place this week at the ExL Effective Business Development for Clinical Trial Service Providers conference in the nation's capital, will give attendees...

New drugs faster from natural compounds: A UC San Diego breakthrough

...of a cyclic NRP. This is called "De Novo sequencing of NRPs." Second, the researchers created "dereplication" tools for moving the other direction: taking the chemical structures of known NRPs and other related information and determining what the data signature would look like if a mass spectrometer had...

Information warfare in the 21st century: Ideas are sometimes stronger than bombs

...he modern field of struggle between a sovereign country and a terrorist organization it is also necessary to relate to the information warfare that is taking place in the new and traditional media as well as other technological platforms, from the Internet to computer games. "The terrorist organizations inv...